2,2'-((3S,6S,9R,15S,18R,21S,24S,30S,31R)-30-((S)-3-((S)-4-amino-2-((S)-2-decanamido-3-(1H-indol-3-yl)propanamido)-4-oxobutanamido)-2,5-dioxopyrrolidin-1-yl)-3-(2-(2-aminophenyl)-2-oxoethyl)-24-(3-aminopropyl)-6-((R)-1-carboxypropan-2-yl)-9-(hydroxymethyl)-18,31-dimethyl-2,5,8,11,14,17,20,23,26,29-decaoxo-1-oxa-4,7,10,13,16,19,22,25,28-nonaazacyclohentriacontane-15,21-diyl)diacetic acid
Daptomycin Impurity 20 is a fully characterized chemical compound used as a reference standard of API Daptomycin. The standard offered is compliant with regulatory guidelines. Daptomycin Impurity 20 is used for analytical method development, method validation (AMV), and Quality Controlled (QC) applications during synthesis and formulation stages of drug development and serves as a reference standard for traceability against pharmacopeial standards (USP or EP). Axios Research products are intended for analytical purposes only and are not for human use. CAS -
Related products
Daptomycin Impurity 33 (Daptomycin beta-isomer diastereomer, Acetate Salt)
M.F. -
M.W. 1620.69; 59.04
CAT# AR-D06105
CAS# NA
Daptomycin Impurity 28 (linear Daptomycin impurity, Acetate Salt)
M.F.
M.W. 1638.71; 59.04
CAT# AR-D06100
CAS# NA
